February 15, 2017 — Deep learning, also known as artificial intelligence, will increasingly be used in the ...
Mercator MedSystems announced that the national co-principal investigators of the company’s DANCE trial each presented comprehensive 13-month trial data during Late-Breaking sessions at ISET (International Symposium on Endovascular Therapy) in Hollywood, Fla., and LINC (Leipzig Interventional Course) in Leipzig, Germany.
Better hospital supply chain management leads to better quality of care and supports patient safety, according to a new Cardinal Health survey of hospital staff and decision makers. Despite respondents rating their supply chain processes as “good,” one in four hospital staff have seen or heard of expired product being used on a patient, and 18 percent have seen or heard of a patient being harmed due to a lack of necessary supplies.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Doctors at the University of Alabama at Birmingham have implemented the first U.S. Food and Drug Administration (FDA)-approved patent foramen ovale occluder in Alabama.
The PRO-Kinetic Energy Cobalt Chromium (CoCr) Coronary Stent System from Biotronik has gained U.S. Food and Drug Administration (FDA) approval utilizing results from the BIOHELIX-I clinical study. This stent, which has already been used to treat more than 650,000 patients worldwide, is now available in the United States.
In the current era of healthcare reform and the push toward evidence-based medicine to both lower costs and improve ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Biotronik has developed an online tool that streamlines the workflow for physicians selecting the right magnetic resonance (MR)-conditional heart monitor or pacing or implantable cardioverter defibrillator (ICD) system for their patients.
The National Institute for Health and Care Excellence (NICE) in the United Kingdom recently issued guidance for use of the HeartFlow FFRct (fractional flow reserve computed tomography) Analysis to help determine the cause of stable chest pain in patients. Developed by HeartFlow Inc., the HeartFlow FFRct Analysis is the first non-invasive technology to provide insight into both the extent of coronary artery disease and the impact that disease has on blood flow to the heart, enabling clinicians to select an appropriate treatment.
Vascular Dynamics Inc. (VDI) announced that the U.S. Food and Drug Administration (FDA) has approved the company’s application to participate in the Expedited Access Pathway (EAP) program for its MobiusHD device for the treatment of resistant hypertension.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
February 13, 2017 — Vital Images Inc. announced that it will be demonstrating new image sharing capabilities for current ...
February 10, 2017 — With the Healthcare Information and Management Systems Society’s annual meeting (HIMSS17) scheduled ...
In the past few years there have been a number of device therapies developed to treat heart failure (HF). This is partly ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
Rep. Tom Price was confirmed by the U.S. Senate as the new secretary of the Department of Health and Human Services (HHS) by a 52-47 vote early Friday morning.
Vital Images Inc. will feature its Vitrea Modular Enterprise Imaging interoperability solutions at the 2017 Healthcare Information and Management Systems Society annual meeting (HIMSS 2017), Feb. 20–23 in Orlando, Fla.
February 9, 2017 — Sir Peter Mansfield, FRS, whose research aided the development of magnetic resonance imaging (MRI) in ...